Unstable angina and arterial hypertension Leszek Kinasz, MD American Heart of Poland Ustron, Poland.

Slides:



Advertisements
Similar presentations
Patient Oriented Therapy Non STE ACS
Advertisements

Management of LCA-LM dissection.
Call for CASES Motaz AbuSamra Krzysztof Milewski CCU, Upper-Silesian Center of Cardiology, Silesian Medical School, Katowice, Poland Head of Department:
Multivessel PCI procedure complicated with fracture of the wire Marcin D ę binski, MD Head: Pawel E. Buszman, MD, FACC University Hospital of Silesia,
The Macstrak Project CCU Case Studies The following is a series of case studies to review different patient types and how they are captured on the form.
British Cardiac Intervention Society Risk Assessment In Acute Coronary Syndromes Dr David Newby BHF Senior Lecturer in Cardiology Associate Director of.
A few basics of cardiac surgery…. Brett Sheridan, MD Assistant Professor Department of Surgery.
Case th May 2005 Stents Infinnium No. 46 Year old Male Smoker, and Hyperlipidemic Unstable Angina.
Ischemic Heart Diseases IHD
HEAPHY 1 & 2 CASE RACE 1 – DIAG Rowena OLIVER Sat 31 st Aug 2013 Session 3 / CR1-6 13:26 – 13:30 OTAGO / SOUTHLAND ABSTRACT A case of a 81 year old female.
Acute Coronary Syndrome. Acute Coronary Syndrome (ACS) Definition of ACS Signs and symptoms of ACS Gender and age related difference in ACS Pathophysiology.
1 Dr. Zahoor Ali Shaikh. 2 CORONARY ARTERY DISEASE (CAD)  CAD is most common form of heart disease and causes premature death.  In UK, 1 in 3 men and.
DEFER STUDY: 5-YEAR FOLLOW-UP A Multicenter Randomized Study
1 What is… ? Disparities Among Women in Acute Cardiac Care Frances Canet, MD Cath Conference Thursday, May 26, 2011.
Call for CASES One Stage Coronary And Peripheral Intervention (OCAPI) in a patient with accelerated diffuse atherosclerosis after chest irradiation. One.
Primary Aim To compare outcomes of participants with symptoms of stable angina or angina equivalent evaluated with an anatomic imaging strategy using CCTA.
Francesco Liistro Cardiovascular Department, Arezzo, Italy Impact of Thrombus Aspiration on Myocardial Tissue Reperfusion and Left Ventricular Functional.
Call for CASES Staged PCI in a patient with multivessel coronary disease disqualified from CABG. Pawel Buszman, MD, FESC, FSCAI Marcin Debinski, MD Krzysztof.
Call for CASES Leszek D. Stachaczyk, MD Pawel Buszman, MD, FESC, FSCAI American Heart of Poland, Ustroñ, Poland & CCU, Upper-Silesian Center of Cardiology,
One stage coronary and peripheral intervention Pawel Buszman, MD, American Heart of Poland, Ustron Silesian Medical School, Katowice.
‘Taxi Driver in Pain’ Tiara Gill Carrie Ross Mark Hambly.
Chaim Lotan MD, Yaron Almagor MD, Karel Kuiper MD, M.J. Suttorp MD, William Wijns MD The SICTO Study CYPHER TM Sirolimus-eluting stent in Chronic Total.
Amr Hassan Mostafa, MD, FSCAI A. Professor of Cardiology Cairo University Cairo, Egypt Egypt Combat MI, March 24-25, Cairo Sheraton.
Dr Jayachandran Thejus.  Coronary artery disease-  Block in coronary artery due to plaque or thrombus  Leads to myocardial ischemia manifested as chest.
Percutaneous closure of a coronary fistula Pawel Buszman, MD Silesian Medical School Katowice, Poland.
Indication and contra-indications for cardiac catheterization
Amy Gutman MD EMS Medication Director
VULNERABLE PLAQUES: Pertinent doubts and solutions in interventional cardiology EuroPCR Paris, 16 May 2006.
Medical Grand Rounds Clinical Vignette October 15 th, 2008 Srikant Duggirala, M.D.
Call for CASES Silesian Medical School, Katowice, Poland Percutenous Controlled Reperfusion For STEMI P iotr P. Buszman.
IVUS evaluation TAP technology for unprotected left main bifurcation lesions interventional therapy Yong-Sheng Ke. MD Department of Cardiology, Yijishan.
One patient, two years, three choices, four PCI ZHAO Peng Cardiology , the Affiliated Hospital of Medical College of CPAPF, Tianjin, China.
Acute Coronary Syndrome
Diagnosis, Management, & Follow-up Care Of CAD/AMI BARRY BERTOLET, MD CARDIOLOGY ASSOCIATES OF NORTH MS.
Introduction Left bundle branch block (LBBB) is notorious for obscuring the ECG diagnosis of acute myocardial infarction (AMI) and, therefore, the decision.
2009 CIT CASE REVIEW Li Weijie Department of Cardiovascular Medicine, Xijing Hospital.
Is the Decision-Making after Failure of CTO Angioplasty Same? Infarct Related CTO or Non- Infarct Related CTO (Continue the Procedure in Other Vessel or.
Treatment of bifurcation lesions is a complex problem Different techniques are commonly used (Y-/T-stenting, „culotte“ technique, „kissing stent“ technique…)
ADMIRALADMIRAL Abciximab before Direct Angioplasty and Stenting in Myocardial Infarction Regarding Acute and Long term follow-up ADMIRAL Study ADMIRAL.
New strategies and perfusion/aspiration devices for primary PCI Sandra Garcia Cruset, PhD. Cordynamic B.U. Marketing Manager.
FRagmin® and Fast Revascularization during InStablity in Coronary artery disease FRISC II.
Late Open Artery Hypothesis Jason S. Finkelstein, M.D. Tulane University Medical Center 2/24/03.
RCA Spasm and VF a case report Qi Zhang, MD Rui Jin Hospital Shanghai Jiao Tong University School of Medicine.
Coronary Angiography, PCI & Cinemaps / Coronary Tree Diagrams Mike McAleer, Charge Nurse Manager CardioVascular Unit (CVU) July 2009.
Ms. Leonardo Roever Coronary Stents. Coronary Artery Disease Leading cause of death in United States for men and women Caused by buildup of plaque in.
Acute Coronary Syndrome
Adel Gamal, MD and Mohamed Saber, Msc
Nightmares in the Cath Lab
Risk Stratification of Chest Pain: Best Practices
Strategies to Improve Inadequate Guide Catheter Support
Interesting Case Presentation
A strange post-CABG presentation
CORONARY ARTERY DISEASE
Clinical Presentation
Tarek Abou Ghazala, MD, FACC, FSCAI
Kansas City, Missouri, USA
The Icahn School of Medicine at Mount Sinai, Mount Sinai Beth Israel
Crescendo angina in Distal Left Main CTO
PCI in patients with cardiogenic shock associated with acute occlusion of the left main coronary artery.
Interesting Case Review
Session Date: 28th Nov’14 Session Time: 14:30 – 16:00
Fractional Flow Reserve Workshop
Case presentantion 73-year old female
Volume 98, Issue 5, Pages (November 1990)
STEMI Equivalents …an opportunity to save myocardium
Coronary Artery Disease 2
What oral antiplatelet therapy would you choose?
Atlantic Cardiovascular Patient Outcomes Research Team
Presentation transcript:

Unstable angina and arterial hypertension Leszek Kinasz, MD American Heart of Poland Ustron, Poland

Clinical data Female, 59 years old Female, 59 years old Unstable angina (CCS class 4) Unstable angina (CCS class 4) Hypertension since 1999, currently required 4 drugs (ACEI, beta-blocker, duretic, calcium channel blocker) Hypertension since 1999, currently required 4 drugs (ACEI, beta-blocker, duretic, calcium channel blocker) Hypercholesterolaemia Hypercholesterolaemia History of pulmonary oedema History of pulmonary oedema BMI 35 BMI 35

Clinical data RR 220/120 RR 220/120 HR 64/min HR 64/min Pulmonary congestion Pulmonary congestion EKG: ST depression and negative T wave in inferior and lateral leads EKG: ST depression and negative T wave in inferior and lateral leads UKG: LVEF 55%, hypokinesia of inferior segments, MVI(+) UKG: LVEF 55%, hypokinesia of inferior segments, MVI(+) Lab tests: CPK, CPK-MB, Troponin I - normal, Creatinine 1.4 mg% Lab tests: CPK, CPK-MB, Troponin I - normal, Creatinine 1.4 mg%

Coronary angiography (CAG) RCA LAO60: 99% lesion in distal segment type B2 LCA RAO30, Caud 15 Normal epicardial segments

PCI: 7F JR guiding cath, 0,014” BMW wire, RCA LAO60: predilatation and stent positioning (BX Velocity 3.0x18 mm) After stenting: max. pressure 18atm

After PCI: Persisted chest pain and ST/T changes on the EKG monitor Persisted chest pain and ST/T changes on the EKG monitor RR 200/120 -a rigorous treatment of hypertension (NTG i.v. and i.a., Furosemid i.v., nifedipine s.l.) without effect on angina RR 200/120 -a rigorous treatment of hypertension (NTG i.v. and i.a., Furosemid i.v., nifedipine s.l.) without effect on angina

What is a cause of the chest pain? Occlusion of a small AM branch? Occlusion of a small AM branch? AM

Hypertension? If so, what should be done next? 1. More intensive pharmacological treatment 2. Further diagnosis of hypertension Hypertension? If so, what should be done next? 1. More intensive pharmacological treatment 2. Further diagnosis of hypertension What is a cause of the chest pain?

Renal angiography Right renal artery Left renal artery Angio performed in AP view, with Right Judkins catheter used previously for PCI

Renal stenting as a one-stage procedure with PCI: Renal stenting: Guiding catheter: 7F, Judkins Right Wire: 0,014” BMW Stent: Corinthian 6.0mm, 14 atm, Left renal artery after stenting

Diagnostic cath, PCI and Renal Stenting as one-stage procedure: Coronary diagnostic catheters:2 Coronary diagnostic catheters:2 No of wires: 1 No of wires: 1 No of guiding catheters:1 No of guiding catheters:1 No of balloon catheters:1 No of balloon catheters:1 No of stents:2 No of stents:2 Contrast: Ultravist 190 ml Contrast: Ultravist 190 ml X-Ray exposition10.5 min. X-Ray exposition10.5 min.

After the procedure No chest pain No chest pain Arterial pressure: 150/90 Arterial pressure: 150/90 Resolution of ST/T changes in serial ECG Resolution of ST/T changes in serial ECG Lab tests on the next day: -cardiac enzymes in normal range -serum creatinine 1.2 mg% Lab tests on the next day: -cardiac enzymes in normal range -serum creatinine 1.2 mg% Hospital stay:36 hours Hospital stay:36 hours

Discussion: Symptoms suggesting renal artery stenosis (RAS) in the presented patient: Symptoms suggesting renal artery stenosis (RAS) in the presented patient: -short history of hypertension -diastolic hypertension resisted to pharmacological treatment -the history of pulmonary oedema despite of preserved global LVEF -short history of hypertension -diastolic hypertension resisted to pharmacological treatment -the history of pulmonary oedema despite of preserved global LVEF

CAD & RAS In 15% of patients undergoing CAG, a significant RAS (>50%) can be found No of narrowed Risk coronary arteriesof RAS 08.8% 110.7% 217.6% 329,9% LM39.0% In 15% of patients undergoing CAG, a significant RAS (>50%) can be found No of narrowed Risk coronary arteriesof RAS 08.8% 110.7% 217.6% 329,9% LM39.0% (The Duke University Experience)

RAS & Risk of MACE AMI AMI Revascularization (PTCA or CABG) Revascularization (PTCA or CABG) No-RASRASp 13.8%41% %58.3%0.01 (The Duke University Experience)

The influence of renal stenting on UA and CHF N=48 pts with UA or CHF and concomitant uni- or bilateral RAS Results: After renal stenting resolution of symptoms in 88% of patients during 8.4 months follow-up. Am J Cardiol 1997;80:363-6

Influence of renal stenting on renal function Circulation 1998;98:642-7 months

Conclusions: Patients with angina and the history suggesting RAS, coronary angiography should be always followed by renal artery angiography. Patients with angina and the history suggesting RAS, coronary angiography should be always followed by renal artery angiography. Renal artery angiography and renal stenting can be performed easily during CAG or PCI as a one stage procedure at the low risk and low additional cost. Renal artery angiography and renal stenting can be performed easily during CAG or PCI as a one stage procedure at the low risk and low additional cost.